EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Pyrosequencing Evaluation of Widely Available Bisulfite Conversion Methods: Considerations for Application

Benedetta Izzi, Alexandra M Binder, Karin B Michels

Medical Epigenetics · 2014

DOI: 10.1159/000358882 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Epigenetics, 2014. Verfasst von Benedetta Izzi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Prevention and Cancer Epidemiology, Freiburg Medical Center, University of Freiburg, Freiburg, Germany ; Obstetrics and Gynecology Epid…. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: NCI NIH HHS, NICHD NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Bisulfite treatment of DNA introduces methylation-dependent sequence changes through selective chemical conversion of nonmethylated cytosine to uracil and serves as pretreatment step for the majority of DNA methylation analysis methods.

Methods

We have evaluated the conversion performance of five of the most commonly used bisulfite treatment kits [MethylDetector (Active Motif), Epitect+ (Qiagen), Zymo Methylation, Zymo Gold and Zymo Lightning (all from Zymo Research)] by pyrosequencing four different regions with variable methylation levels, including: a repetitive element (ALUSX), a gene with low levels of methylation (IL6ST), an imprinted gene expected to be approximately 50% methylated (IGF2), and a fully methylated gene (ST3GAL2). In addition, we have studied the influence of duration (3 vs. 16 h) and type (fixed temperature vs. cycling program) of incubation protocol on the conversion efficiency of each evaluated kit.

Results

All kits produced similar conversion rates of ALUSX,IGF2 and ST3GAL2, while the conversion of the low methylated IL6ST gene was variable between kits. The Zymo kits were highly consistent in their performance even when different protocols of incubation were applied, generating full conversion at the low methylated gene IL6; this was not true for the MethylDetector and Epitect+ kits. However, long-cycling incubation could produce similar conversion rates for the same locus in combination with Active Motif and Qiagen kits.

Conclusions

The selection of a long-cycling protocol during conversion permits standardization of protocols, improving the reproducibility of methylation estimates across laboratories for gene-specific, genome-wide and bisulfite-based sequencing analyses.

Schlagwörter

Stichwörter der Autor:innen

Bisulfite treatmentDNA methylationPyrosequencing Abstract

Autor:innen und Institutionen

  • Institute for Prevention and Cancer Epidemiology, Freiburg Medical Center, University of Freiburg, Freiburg, Germany ; Obstetrics and Gynecology Epidemiology Center, Department of Obstetrics, Gynecology and Reproductive…
  • Harvard School of Public Health, Department of Epidemiology, Boston, Mass., USA.

Förderung

  • NCI NIH HHS
  • NICHD NIH HHS

Zitieren

APA

Izzi, B., Binder, A. M., & Michels, K. B. (2014). Pyrosequencing Evaluation of Widely Available Bisulfite Conversion Methods: Considerations for Application. Medical Epigenetics. https://doi.org/10.1159/000358882

Vancouver

Izzi B, Binder AM, Michels KB. Pyrosequencing Evaluation of Widely Available Bisulfite Conversion Methods: Considerations for Application. Medical Epigenetics. 2014. doi:10.1159/000358882

BibTeX
@article{Izzi2014,
  author = {Izzi, Benedetta and Binder, Alexandra M and Michels, Karin B},
  title = {Pyrosequencing Evaluation of Widely Available Bisulfite Conversion Methods: Considerations for Application},
  journal = {Medical Epigenetics},
  year = {2014},
  doi = {10.1159/000358882}
}
Kostenlos starten →